Neutrophil-derived S100A12 is profoundly upregulated in the early stage of acute Kawasaki disease
Authors:
- Dirk FoellDFDirk Foell
- Kei-Ich HironoKHKei-Ich Hirono
- Thomas VoglTVThomas Vogl
- Chen RuiCRChen Rui
- Xianyi YuXYXianyi Yu
- Sayaka WatanabeSWSayaka Watanabe
- Kazuhiro WatanabeKWKazuhiro Watanabe
- Kei-Ichiro UeseKUKei-Ichiro Uese
- Ikuo HashimotoIHIkuo Hashimoto
- Johannes RothJRJohannes Roth
- Fukiko IchidaFIFukiko Ichida
- 1 September 2004
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 94 (6) , 840-844
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- S100A12 (EN-RAGE) in monitoring Kawasaki diseaseThe Lancet, 2003
- The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responsesJournal of Clinical Investigation, 2001
- Neutrophils and Mononuclear Cells Express Vascular Endothelial Growth Factor in Acute Kawasaki Disease: Its Possible Role in Progression of Coronary Artery LesionsPediatric Research, 2001
- Ulinastatin, an Elastase Inhibitor, Inhibits the Increased mRNA Expression of Prostaglandin H2Synthase–Type 2 in Kawasaki DiseaseThe Journal of Infectious Diseases, 2000
- RAGE Mediates a Novel Proinflammatory AxisCell, 1999
- Long-term Consequences of Kawasaki DiseaseCirculation, 1996
- Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroidsThe Journal of Pediatrics, 1996
- Kawasaki DiseasePediatric Clinics of North America, 1995
- Pathological observations concerning the cardiovascular lesions in Kawasaki diseaseCardiology in the Young, 1991
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR KAWASAKI DISEASEThe Lancet, 1984